Search

Showing 71 - 80 of 532 results.

Overview

LEARN MORE: AMPLATZER™ TALISMAN™ PFO OCCLUDER Clinical data Diagnosis Prevention PFO CLOSURE: BEHIND THE NUMBERS Ischemic strokes are of unknown cause5 Of patients with an isch
Clinical Data

NYHA: New York Heart Association LEARN MORE: CLINICAL Trials Clinical Case Compendium A SOLUTION THAT HAS RECEIVED CLOSE ATTENTION5–7, 10,11 — AND STRONGLY POSITIVE REVIEWS.12
Clinical Data

SWITCH TO THE interventional VIEW For more information specific to interventional cardiology regarding PDA closure CAP=continued access protocol, IDE=investigational device exemption.
Overview

SWITCH TO THE interventional VIEW For more information specific to interventional cardiology regarding PDA closure If PDA is left untreated, the mortality rate is 20% by age 20 years,
Diagnosis

PATENT DUCTUS ARTERIOSUS LEARN MORE: PATIENTS WHO BENEFIT
Overview

LEARN MORE: AMPLATZER™ DUCT OCCLUDERS AMPLATZER™ PICCOLO™ OCCLUDER WATCH ON-DEMAND: PDA Symposium 2024 If PDA is left untreated, the mortality rate is 20% by age 20 years,
Prevention

AF AND THE CHALLENGES OF MEDICATION Many patients at risk of stroke want an alternative to oral anticoagulants (OACs), for example, warfarin and non-vitamin K oral anticoagulants (NOACs).7 40% Do N
Diagnosis

AF AND STROKE ARE OFTEN CONNECTED MORE SEVERE LEARN MORE: PATIENTS WHO BENEFIT Clinical Data
Diagnosis

Characteristics that are strongly associated with a causal role of PFO in an ischemic stroke of unknown cause are:9 Atrial septal aneurysm (ASA) and/or a moderate-to-severe shunt Atrial septal
Diagnosis

Patients with a moderate left-to-right shunt may remain asymptomatic for years. However, historical series have shown that chronic volume overload may ultimately lead to severe complications: Co